Why the study?
Polypharmacy in the elderly is an important issue that increases the risk of adverse drug events, prompting the Japan Geriatrics Society to publish updated guidelines for safe pharmacotherapy.
The 2025 Japan Geriatrics Society guidelines offer practical tools and flowcharts for managing polypharmacy and safely deprescribing medications in elderly patients.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
太郎 小島 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: